ASX climbs, Peak Rare Earths soars 150pc
ASX keeps on trucking, Nvidia flies, iron ore pops and steady jobs data keeps the RBA on ice.
Stockhead
Latest trials offer hope to cancer sufferers
Amplia Therapeutics and Immutep have released clinical trial results that promise more effective treatments for pancreatic and lung cancers.
ASX recovers to post 0.22pc gain
The ASX recovered from an early morning dip, lifted by strong movements in tech and banking stocks to rise 0.22pc.
Chinese producer secures ownership of PEK
Shenghe Resources’ Ganzhou Chenguang signs binding agreement to acquire junior explorer Peak Rare Earths.
More Stories
Long Shortz: Orthocell
Orhtocell gains approval for Remplir sales and distribution in Canada, mere months after getting go ahead in US and Thailand.
CEL closing in on Hualilan gold production
Refurbishment of the Casposo plant will be completed in time for Challenger Gold to start Hualilan toll treatment in the second half of 2025.
Funds for first Igrejinha drilling
The company is moving ahead with drilling plans at the Igrejinha project in Brazil’s Lithium Valley following commitments to raise $500,000 in a placement.
StockTake: QPM Energy
QPM Energy has certified a big increase to reserves as it continues building up its gas resource base in the Sunshine State.
Impedimed ASX
US-focused device maker Impedimed is building a $1.2 million stockpile of Asian-sourced componentry to avoid any fallout from Trump’s tariffs.
StockTake: Koonenberry Gold
Koonenberry Gold is six-for-six on spotting visible gold while drilling its Enmore project in New South Wales.
FDA confirms new trial endpoint for approval
FDA confirmed a new clinical trial endpoint for DMX-200 Phase 3 clinical trial.
VHM eyes potential Goschen offtake deal
VHM Limited’s MoU with Currumbin Minerals sets timeline and framework for collaboration agreement governing sale of Goschen heavy minerals concentrate.
Control Bionics’ growth bounces ahead
Control Bionics reports traction across its core product platforms with growing international partnerships and increasing clinical validation driving growth.
BTR on track to be long-life gold producer
Brightstar Resources is advancing PFS workstreams as it targets gold production at its Sandstone consolidated project by 2028.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/43